fbpx JLABS @ TMC QuickFire Challenge - Challenge | JLABS
JLABS @ TMC QuickFire Challenge

JLABS @ TMC QuickFire Challenge

Challenge ended

Residency at JLABS

Consumer Health


Image paragraph

Developing next-generation surgical adhesives based on polyurethane, which permit quick and safe wound closure, topically as well as inside the human body.

Image paragraph

Aortix is a heart pump implanted without surgery, designed from the ground-up as a safe and effective treatment for chronic heart failure which affects one in five adults in the United States.

Image paragraph

High-throughput antibody discovery platform for breast and other cancers focused on identifying therapeutics targeted at novel antigens induced by the tumor microenvironment. 

Alterna Therapeutics, Inc.

Developing new therapeutics to treat diabetes and obesity.

The Challenge

In honor of the upcoming Grand Opening of JLABS @ TMC, Johnson & Johnson Innovation has launched a QuickFire Challenge to award new game-changing early-stage innovation companies with the use of a bench, workstation and access to the JLABS @ TMC community for one year.